I'd like to see it go to da moon like JDMO/RINO, but I am guessing it settles in at a more modest PPS around the $4-$7 range. This is just a wild ass conjecture though.
It doesn't have the sexy pedigree of being an environmental and/or Chinese company. It's a medical research company, albeit with interesting studies in the treatment of atherosclerosis.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.